Iridex (IRIX) Capital Expenditures Growth (1y) (2012 - 2026)
Iridex (IRIX) Capital Expenditures Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -47.73% |
| 10 | Iridex | 15.36 Mn | 10.77 Mn | 4.74 Mn | 205.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 205.21% |
| Jan 3, 2026 | -320.86% |
| Sep 27, 2025 | 204.64% |
| Jun 28, 2025 | -213.64% |
| Mar 29, 2025 | -3,300.00% |
| Dec 28, 2024 | -30.50% |
| Sep 28, 2024 | -189.88% |
| Jun 29, 2024 | 37.50% |
| Mar 30, 2024 | -93.02% |
| Dec 30, 2023 | 86.92% |
| Sep 30, 2023 | -76.27% |
| Jul 1, 2023 | -95.35% |
| Apr 1, 2023 | 65.38% |
| Dec 31, 2022 | -27.70% |
| Apr 2, 2022 | 149.06% |
| Apr 3, 2021 | -381.82% |
| Sep 26, 2020 | -165.63% |
| Jun 27, 2020 | 1,400.00% |
| Mar 28, 2020 | -22.22% |
| Dec 28, 2019 | -99.18% |